Table 2.
Timeline | June 2016–February 2017 | March 2017 | April 2017 | May 2017 | June 2017 | July 2017 | August 2017 | September 2017 | October 2017 | November 2017 | December 2017 | January 2018 | Final clinic visit | Follow-up 3 months after baseline | Follow-up 6 months after baseline | Follow-up 12 months after baseline | |
Enrolment schedule | HCP cluster random allocation | Patient recruitment during internal pilot phase | Patient recruitment during main trial phase | ||||||||||||||
Intervention schedule | MOC and protocol development | Cluster 1 west | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Cluster 2 central | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | |||||||
Cluster 3 east | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||||
Assessment schedule | Baseline data Internal pilot (T=0) |
Baseline data Main trial (T=0) |
Longitudinal repeated measures in cohorts (T=1), (T=2), (T=3) and (T=4) |
||||||||||||||
Implementation process | PCS | Cluster 1 before and after MOC implementation |
Cluster 2 before and after MOC implementation | Cluster 3 before and after MOC implementation | x | x | |||||||||||
PABS-PT | Cluster 1 before MOC implementation | Cluster 2 before MOC implementation | Cluster 3 before MOC implementation | x | x | ||||||||||||
DIBQ | Cluster 1 after MOC implementation | Cluster 2 after MOC implementation | Cluster 3 after MOC implementation | x | x | ||||||||||||
PROMS | NRS back pain and leg pain | x | x | x | x | x | x | x | x | x | x | x | x | x | |||
ODI | x | x | x | x | x | x | x | x | x | x | x | x | x | ||||
EQ-5D | x | x | x | x | x | x | x | x | x | x | x | x | x | ||||
BIPQ | x | x | x | x | x | x | x | x | x | x | x | x | x | ||||
PEI | x | x | x | ||||||||||||||
Satisfaction | x | x | x | ||||||||||||||
PGIC | x | x | x | ||||||||||||||
Implementation outcomes | HCP assessment, diagnosis and treatment codes | x | x | x | x | x | x | x | x | x | x | x | |||||
Referrals to specialist care | x |
0, control condition; 1, intervention condition; grey-shaded cells, internal pilot; T, assessment time. Period where 2-week crossover from control to intervention can occur dependent on patient recruitment rates identified in the internal pilot study.
BIPQ, Brief Illness Perception Questionnaire; DIBQ, Determinants of Implementation Behaviour Questionnaire; EQ-5D, EuroQoL 5-Dimension Questionnaire; HCP, healthcare practitioner; MOC, model of care; NRS, Numeric Rating Scale; ODI, Oswestry Disability Index; PABS-PT, Pain Attitudes and Beliefs Scale for physical therapists; PCS, Practitioner Confidence Scale; PEI, Patient Enablement Index; PGIC, Patient Global Rating of Change; PROMS, patient-reported outcome measures.